Fig. 1 | Hypertension Research

Fig. 1

From: Effect of a novel nonsteroidal selective mineralocorticoid receptor antagonist, esaxerenone (CS-3150), on blood pressure and renal injury in high salt-treated type 2 diabetic mice

Fig. 1

Effects of esaxerenone (EXR) and spironolactone (SPL) on body weight (a), systolic blood pressure (b), fasting blood glucose (c), plasma insulin (d) and albuminuria (e). NS, normal salt diet; HS, high salt diet; UACR, Urinary albumin/creatinine ratio; C57BL/6, C57BL/6 mice; KK-Ay, KK-Ay mice. aP < 0.05 vs. KK-Ay + HS. bP < 0.05, KK-Ay + HS + EXR vs. KK-Ay + HS + SPL

Back to article page